Home / Uncategorized / New melanoma drug doubles survival time, study shows

New melanoma drug doubles survival time, study shows

Posted by: Philippe Matthews in Uncategorized Comments Off on New melanoma drug doubles survival time, study shows 222 Views

Patients with metastatic melanoma typically live six to ten months; Zelboraf prolonged life expectancy to 16 months

Read the rest here:
New melanoma drug doubles survival time, study shows

If you enjoyed this post, make sure you subscribe to my RSS feed!

Tagged with:

About Philippe Matthews

© 2014 the PM show – If You Like O, You Will Love P. All Rights Reserved. |A My Internet Marketing Expert Production
Scroll To Top